Your browser does not appear to support JavaScript. You may want to try one of the following:
You may want to try one of the following:
If the above does not work, try reloading the page yourself. Note that you will lose any unsaved changes:
shift
control
Show details
Hide details
This form has to be reloaded. This most likely happened because your session has expired, which might take to the login page. (If you think that you shouldn't see this message and that the problem persists, please contact support.)
C-CDA and IHE PCC (and epSOS) use different elements to map the kind of propensity.obs.code in IHE PCC / epSOS obs.value in C-CDA
Agree a common solution for expressing the kind of propensity identifying pro and contra of both approaches
-
Identify a suitable value set for the allergy/intollernace agents.
suggested to consider the SNOMED CT terapeutic and non terapeutic substances.Call 2016-12-05
At this stage consider substances and not products (product identifiers are rarely usable cross-jurisdictions).mentioned code systems (SNOMED CT, ATC,...)To be better analyzed if we should require the usage of that value set or consider it a suggested value set.
The <text> element at the entry level is required for this (and other entries) for IHE PCC (and epSOS) , optional for the C-CDA.The text is used there as reference pointing to the narrative (the <reference> element is required).To be agreed a common approach for this element here and for the other entries.Suggestion:
Consider to add a schematron assert for the constraint "If this condition is known to be resolved, then the effectiveTime/high would be present."
There are two different templates used for the problem statuses one for the allergy and one for the problems.Check the differences and use only one if possible.